Patents by Inventor Eric P. Gillis

Eric P. Gillis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12129255
    Abstract: The compound and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: October 29, 2024
    Assignee: ViiV Healthcare UK (No. 5) Limited
    Inventors: Eric P. Gillis, Christiana Iwuagwu
  • Publication number: 20230355626
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: March 3, 2021
    Publication date: November 9, 2023
    Inventors: Eric P. GILLIS, Christiana IWUAGWU
  • Publication number: 20230149408
    Abstract: A pharmaceutical composition comprising the compound of Formula Ia, Formula Ib, Formula Ic, or Formula Id, or a pharmaceutically acceptable salt thereof, is set forth.
    Type: Application
    Filed: April 13, 2021
    Publication date: May 18, 2023
    Inventors: Kyle E. PARCELLA, Gautam DALWADI, Eric P. GILLIS, Dawn D. PARKER
  • Publication number: 20230109662
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: September 30, 2022
    Publication date: April 6, 2023
    Inventors: Eric P. GILLIS, Kyle E. PARCELLA, Manoj PATEL, Kevin M. PEESE
  • Publication number: 20230106880
    Abstract: A compound of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: March 3, 2021
    Publication date: April 6, 2023
    Inventors: Eric P. GILLIS, Christiana IWUAGWU
  • Publication number: 20230013823
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: October 2, 2020
    Publication date: January 19, 2023
    Inventors: Michael S. BOWSHER, Eric P. GILLIS, B. Narasimhulu NAIDU, Kyle E PARCELLA, Manoj PATEL
  • Patent number: 11541055
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: January 3, 2023
    Assignee: ViiV Healthcare UK (No.5) Limited
    Inventors: Eric P. Gillis, Kyle E. Parcella, Manoj Patel
  • Publication number: 20220389007
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: September 29, 2020
    Publication date: December 8, 2022
    Inventors: Michael S. BOWSHER, Eric P. GILLIS, Christiana IWUAGWU, B Narasimhulu NAIDU, Kyle E. PARCELLA, Manoj PATEL
  • Publication number: 20220370451
    Abstract: Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
    Type: Application
    Filed: October 6, 2020
    Publication date: November 24, 2022
    Inventors: Michael S. BOWSHER, Eric P. GILLIS, Kyle E. PARCELLA, Christiana IWUAGWU
  • Patent number: 11505543
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: November 22, 2022
    Assignee: VIIV HEALTHCARE UK (NO.5) LIMITED
    Inventors: Makonen Belema, John A. Bender, David B. Frennesson, Eric P. Gillis, Christiana Iwuagwu, John F. Kadow, B. Narasimhulu Naidu, Kyle E. Parcella, Kevin M. Peese, Ramkumar Rajamani, Mark G. Saulnier, Alan Xiangdong Wang, Manoj Patel, Michael S. Bowsher
  • Publication number: 20210403465
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: October 28, 2019
    Publication date: December 30, 2021
    Inventors: Eric P. GILLIS, Kyle E. PARCELLA, Michael S. BOWSHER
  • Publication number: 20210395248
    Abstract: Compounds of Formula I, and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: November 4, 2019
    Publication date: December 23, 2021
    Inventors: Michael S. BOWSHER, Eric P. GILLIS, Christiana IWUAGWU, Kyle E. PARCELLA, Kevin M. PEESE
  • Publication number: 20210393633
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: October 22, 2019
    Publication date: December 23, 2021
    Inventors: Eric P. GILLIS, Kyle E. PARCELLA, Manoj PATEL, B. Narasimhulu NAIDU
  • Publication number: 20210395262
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
    Type: Application
    Filed: October 22, 2019
    Publication date: December 23, 2021
    Inventors: Eric P. GILLIS, Kyle E. PARCELLA, Manoj PATEL, Christiana IWUAGWU, Michael S. BOWSHER, Alan Xiangdong WANG
  • Publication number: 20210379071
    Abstract: Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
    Type: Application
    Filed: November 4, 2019
    Publication date: December 9, 2021
    Inventors: Michael S. BOWSHER, Eric P. GILLIS, Christiana IWUAGWU, B. Narasimhulu NAIDU, Kyle E. PARCELLA, Manoj PATEL, Kevin M. PEESE
  • Publication number: 20210323967
    Abstract: The compound and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.
    Type: Application
    Filed: June 17, 2020
    Publication date: October 21, 2021
    Inventors: Eric P. GILLIS, Christiana IWUAGWU
  • Publication number: 20210024503
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: April 11, 2019
    Publication date: January 28, 2021
    Inventors: Makonen BELEMA, John A. BENDER, David B. FRENNESSON, Eric P. GILLIS, Christiana IWUAGWU, John F. KADOW, B. Narasimhulu NAIDU, Kyle E. PARCELLA, Kevin M. PEESE, Ramkumar RAJAMANI, Mark G. SAULNIER, Alan Xiangdong WANG, Manoj PATEL, Michael S. BOWSHER
  • Publication number: 20210009508
    Abstract: Provided are methods for making and using chiral, non-racemic protected organoboronic acids, including pinene-derived iminodiacetic acid (PIDA) boronates, to direct and enable stereoselective synthesis of organic molecules. Also provided are methods for purifying PIDA boronates from solution. Also provided are methods for deprotection of boronic acids from their PIDA ligands. The purification and deprotection methods may be used in conjunction with methods for coupling or otherwise reacting boronic acids. Iterative cycles of deprotection, coupling, and purification can be performed to synthesize chiral, non-racemic compounds. The methods are suitable for use in an automated chemical synthesis process. Also provided is an automated small molecule synthesizer apparatus for performing automated stereoselective synthesis of chiral, non-racemic small molecules using iterative cycles of deprotection, coupling, and purification.
    Type: Application
    Filed: July 23, 2020
    Publication date: January 14, 2021
    Inventors: Martin D. Burke, Junqi Li, Eric P. Gillis
  • Publication number: 20200360384
    Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
    Type: Application
    Filed: October 22, 2019
    Publication date: November 19, 2020
    Inventors: Eric P. GILLIS, Kyle E. PARCELLA, Manoj PATEL, Kevin M. PEESE
  • Patent number: 10752577
    Abstract: Provided are methods for making and using chiral, non-racemic protected organoboronic acids, including pinene-derived iminodiacetic acid (PIDA) boronates, to direct and enable stereoselective synthesis of organic molecules. Also provided are methods for purifying PIDA boronates from solution. Also provided are methods for deprotection of boronic acids from their PIDA ligands. The purification and deprotection methods may be used in conjunction with methods for coupling or otherwise reacting boronic acids. Iterative cycles of deprotection, coupling, and purification can be performed to synthesize chiral, non-racemic compounds. The methods are suitable for use in an automated chemical synthesis process. Also provided is an automated small molecule synthesizer apparatus for performing automated stereoselective synthesis of chiral, non-racemic small molecules using iterative cycles of deprotection, coupling, and purification.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: August 25, 2020
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Martin D. Burke, Junqi Li, Eric P. Gillis